China Universal Asset Management Company’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$746K Sell
18,373
-7,063
-28% -$243K 0.04% 231
2026
Q1
$801K Buy
25,436
+8,185
+47% +$236K 0.06% 218
2025
Q4
$428K Sell
17,251
-1,215
-7% -$24.4K 0.03% 273
2025
Q3
$300K Sell
18,466
-2,654
-13% -$37.6K 0.02% 293
2025
Q2
$277K Buy
21,120
+2,127
+11% +$30.7K 0.03% 285
2025
Q1
$418K Sell
18,993
-1,084
-5% -$28.4K 0.04% 261
2024
Q4
$536K Buy
20,077
+2,042
+11% +$65K 0.05% 243
2024
Q3
$481K Buy
18,035
+7,062
+64% +$140K 0.05% 224
2024
Q2
$198K Sell
10,973
-6,908
-39% -$120K 0.03% 246
2024
Q1
$326K Buy
17,881
+10,543
+144% +$168K 0.04% 230
2023
Q4
$80.3K Buy
7,338
+5,704
+349% +$40K 0.02% 310
2023
Q3
$9.36K Buy
1,634
+805
+97% +$5.47K ﹤0.01% 350
2023
Q2
$6.42K Sell
829
-28
-3% -$236 ﹤0.01% 346
2023
Q1
$5.72K Buy
857
+215
+33% +$1.99K ﹤0.01% 351
2022
Q4
$5.74K Buy
642
+175
+37% +$1.64K ﹤0.01% 282
2022
Q3
$5K Buy
+467
New +$4.72K ﹤0.01% 270

Other funds holding EWTX

China Universal Asset Management Company's EWTX Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Edgewise Therapeutics (EWTX) stake by 28% in Q2 2026, selling an estimated $243K and leaving 18,373 shares worth $746K. The position accounts for 0.04% of the portfolio, ranked #231.

China Universal Asset Management Company first reported a position in EWTX in Q3 2022 and has held it in 16 quarters since. The position peaked at $801K in Q1 2026. 105 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • China Universal Asset Management Company held 18,373 shares of Edgewise Therapeutics worth $746K as of Q2 2026.
  • China Universal Asset Management Company sold 7,063 Edgewise Therapeutics shares in Q2 2026, an estimated $243K.
  • Edgewise Therapeutics made up 0.04% of China Universal Asset Management Company's portfolio in Q2 2026, its #231 holding.
  • China Universal Asset Management Company first reported a position in Edgewise Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Edgewise Therapeutics position peaked at $801K in Q1 2026.
  • 105 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.